NatureWise Biotech & Medicals Corporation (TPEX:4732)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
22.20
+0.20 (0.91%)
Jul 18, 2025, 11:18 AM CST
-14.29%
Market Cap1.09B
Revenue (ttm)224.32M
Net Income (ttm)897.00K
Shares Out49.38M
EPS (ttm)0.02
PE Ratio1,211.02
Forward PEn/a
Dividend0.20 (0.88%)
Ex-Dividend DateAug 27, 2024
Volume8,254
Average Volume14,051
Open22.95
Previous Close22.00
Day's Range22.00 - 22.95
52-Week Range17.40 - 27.85
Beta0.64
RSI44.50
Earnings DateAug 13, 2025

About TPEX:4732

NatureWise Biotech & Medicals Corporation engages in the development of therapeutic drugs in Taiwan. It offers LipoCol Forte, a capsule for hypercholesterolemia and hypertriglyceridemia; PPL Taiwan green propolis; and NBM-BMX, an oral softgel capsule to treat cancer. The company was founded in 2000 and is based in Taipei, Taiwan. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2000
Employees 32
Stock Exchange Taipei Exchange
Ticker Symbol 4732
Full Company Profile

Financial Performance

In 2024, TPEX:4732's revenue was 224.32 million, an increase of 40.08% compared to the previous year's 160.14 million. Earnings were 897,000, a decrease of -91.14%.

Financial Statements

News

There is no news available yet.